Suramin inhibits theIn Vitro expression of encephalitis B virus proteins NS3 and E

Abstract

In this study, the mechanism by which Suramin inhibits the replication of epidemic encephalitis B virus was explored to provide a theoretical basis for its further application in clinical practice. After viral infection of HepG2 and IMR-32 cells, different concentrations of Suramin were added to the culture media, and then the cultural supernatants and infected cells were collected 48 h later. For the evaluation of the curative effect, cytopathic effect (CPE), virus titers, the expression of viral protein and viral RNA were determined by Western blot RT-PCR andin vitro RNA synthesis, respectively. At the concentration of 50 μg/ml of Suramin, HepG2 and IMR-32 infected with epidemic encephalitis B virus decreased by 51.8% and 0.03% respectively, as compared with controls. It was suggested that expression of encephalitis B virus proteins NS3 and E was notably reduced by Suramin. This is especially true of E protein. At RNA level, however, no difference in RNA virus was found between Suramin-treated virus and non-treated cells. Our results suggest that Suramin can inhibit viral replication by blocking the production of viral proteins.

Keywords

Suramin / antiviral activity / encephalitis B virus

References

[1] PurzycL, CalkosinskiX. The influence of mechlorethamine on the activity of ecto-ATPase of rat lymphocytes. Ann Pharm Fr, 2001, 59(1): 33-33

[2] GutierrezA M, LouX, ErikA, et al.. Ca²⁺ response of rat mesangial cells to ATP analogues. Eur J Pharmacol, 1999, 369(1): 107-107

[3] FilippiS, AmeriniS, MaggiM, et al.. Studies on the mechanisms involved in the ATP-induced relaxation in human and rabbit corpus cavernosum. J Urol, 1999, 16(1): 326-326

[4] Huber-LangM, FischerK G, GloyJ, et al.. UTP and ATP induce different membrane voltage responses in rat mesangial cells. Am J Physiol, 1997, 272(6): 704-704

[5] SteinC A. Suramin: A novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res, 1993, 53: 2239-2239

[6] EdwardZ, TakegamiT. Localization and function of Japanese encephalitis virus nonstructural protein NS3 and NS5 for viral RNA synthesis in the infected cells. Microbil Immunol, 1993, 37: 239-239

[7] TakegamiT, HottaS. In vitro synthesis of Japanese encephalitis virus (JEV) RNA: Membrane and nuclear fractions of JEV-infected cells possess high levels of virus-specific RNA polymerase activity. Virus Res, 1989, 13: 337-337

[8] MiddaughC R, MachH, BurkeC J, et al.. Nature of the interaction of growth factors with Suramin. Biochemistry, 1992, 31: 9016-9016

[9] TakegamiT, SkamuroD, FurukawaT. Japanese encephalitis nonstructural protein NS3 has RNA binding and ATPase activities. Virus Genes, 1994, 9: 105-105

[10] CooperM, LiebemanR, LaRoccaR, et al.. Adaptive control with feedback strategies for Suramin dosing. Clin Pharmacol Ther, 1992, 53: 11-11